TBI: Vasopharm GmbH Announces Post Hoc Analyses of…
WÜRZBURG, Germany, Feb. 8, 2022 -- Vasopharm GmbH ("vasopharm"), a privately-held…
WÜRZBURG, Germany, Feb. 8, 2022 -- Vasopharm GmbH ("vasopharm"), a privately-held…
How S.N. Subrahmanyan’s Proposal of 90-Hour Workweeks Is Shaping Conversations…